Ocugen, Inc. (OCGN)
1.32
-0.05
(-3.65%)
USD |
NASDAQ |
Aug 28, 16:00
1.33
+0.01
(+0.76%)
After-Hours: 20:00
Ocugen Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 97.32 |
| June 26, 2026 | 87.41 |
| June 25, 2026 | 79.84 |
| June 24, 2026 | 81.00 |
| June 23, 2026 | 80.42 |
| June 22, 2026 | 75.17 |
| June 18, 2026 | 72.26 |
| June 17, 2026 | 71.68 |
| June 16, 2026 | 68.76 |
| June 15, 2026 | 71.10 |
| June 12, 2026 | 70.51 |
| June 11, 2026 | 71.10 |
| June 10, 2026 | 69.35 |
| June 09, 2026 | 72.26 |
| June 08, 2026 | 73.43 |
| June 05, 2026 | 74.59 |
| June 04, 2026 | 79.84 |
| June 03, 2026 | 75.76 |
| June 02, 2026 | 78.09 |
| June 01, 2026 | 79.84 |
| May 29, 2026 | 80.42 |
| May 28, 2026 | 82.17 |
| May 27, 2026 | 80.42 |
| May 26, 2026 | 78.09 |
| May 22, 2026 | 78.09 |
| Date | Value |
|---|---|
| May 21, 2026 | 78.67 |
| May 20, 2026 | 79.25 |
| May 19, 2026 | 75.76 |
| May 18, 2026 | 78.09 |
| May 15, 2026 | 81.00 |
| May 14, 2026 | 85.08 |
| May 13, 2026 | 85.66 |
| May 12, 2026 | 85.66 |
| May 11, 2026 | 86.25 |
| May 08, 2026 | 87.99 |
| May 07, 2026 | 83.92 |
| May 06, 2026 | 84.79 |
| May 05, 2026 | 86.83 |
| May 04, 2026 | 107.81 |
| May 01, 2026 | 104.89 |
| April 30, 2026 | 100.82 |
| April 29, 2026 | 97.90 |
| April 28, 2026 | 96.74 |
| April 27, 2026 | 99.07 |
| April 24, 2026 | 96.74 |
| April 23, 2026 | 97.32 |
| April 22, 2026 | 97.90 |
| April 21, 2026 | 103.15 |
| April 20, 2026 | 107.81 |
| April 17, 2026 | 115.97 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Biogen, Inc. | 1.712 |
| Gilead Sciences, Inc. | 15.28 |
| MannKind Corp. | -- |
| Vertex Pharmaceuticals, Inc. | 6.778 |
Price to Book Value Related Metrics
| PS Ratio | 92.41 |
| PEG Ratio | -0.1785 |
| Price | 1.32 |
| Earnings Yield | -19.30% |
| Market Cap | 447.54M |
| PEGY Ratio | -0.1785 |